SUSTAINED RELEASE FORMULATION AND IN-VITRO EVALUATION OF IBUPROFEN-HPMC MATRIX TABLETS

AuthorMA Dabbaghen
AuthorL Beitmashalen
Issued Date2006-12-20en
AbstractIbuprofen is one of the safest and most potent non-steroidal anti-inflammatory drug (NSAID) available in the market. To improve the bioavailability of ibuprofen, a thorough preformulation trial was undertaken. As a part of these studies, different formulations of ibuprofen containing different amounts of hydroxypropylmethylcellulose (HPMC) and microcrystalline cellulose (Avicel®) were made and evaluated. The superior formulation which released the drug at constant rate of about 60 mg/hour was chosen. Then the effect of changing particle size of granulation was studied. Two different crystal forms of ibuprofen were prepared and their release pattern were studied. Produced crystal forms of ibuprofen showed different release mechanisms in comparison with the original form.  Incorporation of various proportions of tween 80 and Sodium Lauryl Sulfate (SLS) as wetting agent on the release rate of ibuprofen in the formulations were also studied. Sodium lauryl sulphate disintegrated the tablets faster than tween 80.en
DOIhttps://doi.org/en
KeywordIbuprofenen
KeywordHPMCen
KeywordMatrix tabletsen
KeywordDissolutionen
KeywordSodium Luryl Sulphateen
KeywordTween 80.en
PublisherBrieflandsen
TitleSUSTAINED RELEASE FORMULATION AND IN-VITRO EVALUATION OF IBUPROFEN-HPMC MATRIX TABLETSen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
75759-pdf.pdf
Size:
87.83 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF